- Datum04.11.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalterstock3 
Sagimet Biosciences Chart

Charts analysieren 
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
 Chart analysieren 

Sagimet Biosciences Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen | 
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Baader | VK | 
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask | 
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,47 %
Intraday
-9,52 %
1 Woche
18,48 %
1 Monat
83,78 %
Seit Jahresbeginn
60,58 %
1 Jahr
Passender Service zu Sagimet Biosciences
Webinar zu Sagimet Biosciences
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,730-11,410
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Sagimet Biosciences
Keine Dividenden verfügbar
Termine von Sagimet Biosciences
Keine aktuellen Termine
Beschreibung
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
